Protein Bioinformatics Research Group
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025

Publications

81. Tusnády, GE and Simon, I (2001) The HMMTOP transmembrane topology prediction server. Bioinformatics 17: 849-50.
[ PubMed ] [ DOI ] [Research topic(s): topology]
82. Tompa, P, Tusnády, GE, Cserzo, M and Simon, I (2001) Prion protein: evolution caught en route. Proc Natl Acad Sci U S A 98: 4431-6.
83. Tusnády, GE and Simon, I (2001) Topology of membrane proteins. J Chem Inf Comput Sci 41: 364-8.
84. Bakos, É, Evers, R, Calenda, G, Tusnády, GE, Szakács, G, Váradi, A and Sarkadi, B (2000) Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). J Cell Sci 113 Pt 24: 4451-61.
85. Tusnády, GE and Váradi, A (1998) Short MRP may not be short. Biochem Biophys Res Commun 242: 465-6.
86. Bakos, É, Evers, R, Szakács, G, Tusnády, GE, Welker, E, Szabó, K, de Haas, M, van Deemter, L, Borst, P, Váradi, A and Sarkadi, B (1998) Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 273: 32167-75.
87. Tusnády, GE and Simon, I (1998) Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J Mol Biol 283: 489-506.
[ PubMed ] [ DOI ] [Research topic(s): topology]
88. Váradi, A, Tusnády, GE, Bakos, É and Sarkadi, B (1998) Membrane topology of the human multidrug resistance-associated protein (MRP) and its homologs. Cytotechnology 27: 71-9.
89. Tusnády, GE, Bakos, É, Váradi, A and Sarkadi, B (1997) Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett 402: 1-3.
90. Bakos, É, Hegedűs, T, Holló, Z, Welker, E, Tusnády, GE, Zaman, GJ, Flens, MJ, Váradi, A and Sarkadi, B (1996) Membrane topology and glycosylation of the human multidrug resistance-associated protein. J Biol Chem 271: 12322-6.